Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplant. 2018 Sep;53(9):1188-1192. doi: 10.1038/s41409-018-0135-3. Epub 2018 Mar 15.

¹ Department of Haematology and Medical Oncology, Clinic of Internal Medicine II, University Hospital Jena, Jena, Germany.
² Department of Haematology, Oncology and Hemostaseology, University Clinical Center, University of Leipzig, Leipzig, Germany.
³ WiSP Wissenschaftlicher Service Pharma GmbH, Langenfeld, Germany.
⁴ Department of Bone Marrow Transplantation, West German Cancer Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.
⁵ Department of Haematology, Oncology, Palliative Care, University of Rostock, Rostock, Germany.
⁶ Department of Hematology, Oncology and Tumorimmunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
⁷ Internal Medicine C (Hematology and Oncology, Palliative Care, Transplant Centre), University Hospital Greifswald, Ernst-Moritz-Arndt-University, Greifswald, Germany.
⁸ Department of Haematology and Medical Oncology, Clinic of Internal Medicine II, University Hospital Jena, Jena, Germany. [email protected].

No abstract available

Publication types